High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia

Atherosclerosis

Volumn 152, Issue 2, 2000, Pages 415-420

  Matsumoto, Kazunari ^a   Miyake, Seibei ^a   Yano, Mayumi ^a   Ueki, Yukitaka ^a   Tominaga, Yuko ^a  

^a SASEBO CHUO HOSPITAL   (Japan)

Author keywords

Adhesion molecule; E selectin; Hyperinsulinemia; Impaired glucose tolerance; Insulin resistance

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOSE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

E-SELECTIN; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033816686     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00487-6     Document Type: Article

References (34)

1. Carter A.M., Grant P.J. Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus. Diabet. Med. 14:1997;423-432.
2. Richardson M., Hadcock S.J., DeReske M., Cybulsky M.I. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler. Thromb. 14:1994;760-769.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
4. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today. 14:1993;506-512.
5. Ceriello A., Falleti E., Bortolotti N., Motz E., Cavarape A., Russo A., Gonano F., Bartoli E. Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism. 45:1996;498-501.
6. Otsuki M., Hashimoto K., Morimoto Y., Kishimoto T., Kasayama D. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes. 46:1997;2096-2101.
7. Olson J.A., Whitelaw C.M., McHardy K.C., Pearson D.W.M., Forrester J.V. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia. 40:1997;1166-1171.
8. Cominacini L., Pasini A.F., Garbin U., Davoli A., De Santis A., Campagnola M., Rigoni A., Zenti M.G., Moghetti P., Lo Cascio V. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia. 38:1995;1122-1124.
9. Fasching P., Waldhäusl W., Wagner O.F. Elevated circulating adhesion molecules in NIDDM-potential mediators in diabetic macroangiopathy. Diabetologia. 39:1996;1242-1244.
10. Cominacini L., Pasini A.F., Garbin U., Campagnola M., Davoli A., Rigoni A., Zenti M.G., Pastorino A.M., Lo Cascio V. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress. Diabetologia. 40:1997;584-589.
11. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
12. Kaplan N.M. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149:1989;1514-1520.
13. DeFronzo R.A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
14. Lillioja S., Mott D.M., Howard B.V., Bennett P.H., Yki-Jarvinen H., Freymond D., Nyomba B.L., Zurlo F., Swinburn B., Bogardus C. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. New Engl. J. Med. 318:1988;1217-1225.
15. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 15:1992;318-368.
16. Matsumoto K., Miyake S., Yano M., Ueki Y., Yamaguchi Y., Akazawa S., Tominaga Y. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects. Diabetes Care. 20:1997;1562-1568.
17. Taniguchi A., Nakai Y., Doi K., Fukushima M., Nagata I., Kawamura H., Imura H., Suzuki M., Tokuyama K. Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis. Diabetes. 43:1994;1211-1217.
18. The expert committee on the diagnosis and classification of diabetes mellitus: report of the Expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care 1997;20:1183-1197.
19. Steiner M., Reinhardt K.M., Krammer B., Ernst B., Blann A.D. Increased levels of soluble adhesion molecules in type 2 (non-insulin-dependent) diabetes mellitus are independent of glycaemic control. Thromb. Haemost. 72:1994;979-984.
20. Baumgartner-Parzer S.M., Wagner L., Pettermann M., Gessl A., Waldhäusl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia. 38:1995;1367-1370.
21. Blann A.D., McCollum C.N. Circulating endotherial cell/leukocyte adhesion molecules in atherosclerosis. Thromb. Haemost. 72:1994;151-154.
22. Hwang S.J., Ballantyne C.M., Sharrett A.R., Smith L.C., Davis C.E., Gotto A.M., Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation. 96:1997;4219-4225.
23. Peter K., Nawroth P., Conradt C., Nordt T., Weiss T., Boehme M., Wunsch A., Allenberg J., Kubler W., Bode C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin and thrombomodulin. Arterioscler. Thromb. Vasc. Biol. 17:1997;505-512.
24. Kautzky-Willer A., Fasching P., Jilma B., Waldhäusl W., Wagner O.F. Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus. J. Clin. Endocrinol. Metab. 82:1997;4117-4121.
25. Bannan S., Mansfield M.W., Grant P.J. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia. 41:1998;460-466.
26. Blann A.D., Tse W., Maxwell S.J.R., Waite M.A. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J. Hypertens. 12:1994;925-928.
27. Allen S., Khan S., Al-Mohanna F., Batten P., Yacoub M. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J. Clin. Invest. 101:1998;1064-1075.
28. Ferri C., Desideri G., Baldoncini R., Bellini C., De Angelis C., Mazzocchi C., Santucci A. Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes. 47:1998;660-667.
29. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., Alberiche M., Bonadonna R.C., Muggeo M. Prevalence of insulin resistance in metabolic disorders. Diabetes. 47:1998;1643-1649.
30. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. J. Clin. Invest. 97:1996;2601-2610.
31. Zeng G., Quon M.J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. J. Clin. Invest. 98:1996;894-898.
32. De caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. J. Clin. Invest. 96:1995;60-68.
33. Cominacini L., Garbin U., Pasini A.F., Campagnola M., Davoli A., Foot E., Sighieri G., Sironi A.M., Lo Cascio V., Ferrannini E. Troglitazone reduces LDL oxidation and lowers plasma E-selectin concentration in NIDDM patients. Diabetes. 47:1998;130-133.
34. Albertini J.P., Valensi P., Lormeau B., Aurousseau M.H., Ferriere F., Attali J.R., Gattegno L. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Diabetes Care. 21:1998;1008-1013.